Tumour doom pill: Cancer drug wipes out all trace of disease in 1 in 12 patients
A daily pill called daraxonrasib, taken with chemotherapy, left five of 61 patients with advanced pancreatic cancer with no detectable tumours. Dr Wungki Park of Memorial Sloan Kettering presented the findings in Barcelona. Tumours shrank or vanished in 60.7 per cent of patients, and 76.6 per cent were alive after a year, against a typical 40 to 45 per cent on chemotherapy alone. The trial had no chemotherapy-only group, it is too early to know whether the cancer will return, and a phase-three trial is now recruiting.
Read from a copy of the story at yahoo.com.
Why it matters: Advanced pancreatic cancer is hard to treat, and this pill plus chemotherapy shrank tumours in most of 61 patients, but with no control group, a phase-three trial must confirm it.
Comments
No comments yet.